Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert J van Leenders

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Translational Andrology and Urology|March 30, 2018
On cribriform prostate cancerCharlotte F Kweldam, Theodorus van der Kwast, Geert J van Leenders
The Prostate|May 26, 2017
Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillanceLeonard P Bokhorst, Monique J Roobol, Chris H Bangma, et al.
BJU International|August 20, 2008
Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancerJoost L Boormans, Mark F Wildhagen, Chris H Bangma, et al.
European Urology|December 15, 2015
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging ScansArnout R Alberts, Ivo G Schoots, Leonard P Bokhorst, et al.
BJU International|March 8, 2017
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancerArnout R Alberts, Monique J Roobol, Frank-Jan H Drost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2017
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamArnout R Alberts, Leonard P Bokhorst, Charlotte F Kweldam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2016
Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsyCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
Histopathology|November 3, 2017
Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7Esther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2017
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancerCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2016
Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinomaCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Translational Andrology and Urology|March 30, 2018
On cribriform prostate cancerCharlotte F Kweldam, Theodorus van der Kwast, Geert J van Leenders
The Prostate|May 26, 2017
Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillanceLeonard P Bokhorst, Monique J Roobol, Chris H Bangma, et al.
BJU International|August 20, 2008
Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancerJoost L Boormans, Mark F Wildhagen, Chris H Bangma, et al.
European Urology|December 15, 2015
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging ScansArnout R Alberts, Ivo G Schoots, Leonard P Bokhorst, et al.
BJU International|March 8, 2017
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancerArnout R Alberts, Monique J Roobol, Frank-Jan H Drost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2017
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamArnout R Alberts, Leonard P Bokhorst, Charlotte F Kweldam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2016
Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsyCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
Histopathology|November 3, 2017
Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7Esther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2017
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancerCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2016
Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinomaCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
Pageof 2